get a key
steadybase-$ company TPST
account_id none on file
legal_name Tempest Therapeutics, Inc.
ticker TPST
cik 1544227
domain tempesttx.com
entry_point_account_id none on file
name Tempest Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Brisbane, CA, United States
calls 0 filings 5 executives 4 family 0
why_nownone on file
callsnone on file
filings
As a result of the ongoing strategic review and the reduction in force, we expect research and development expenses will decrease period over period.

filing / Aug 13, 2026 / receipt

As a result of the ongoing strategic review and the reduction in force, we expect general and administrative expenses will decrease period over period.

filing / Aug 13, 2026 / receipt

Our material cash requirements primarily relate to our operating leases for office space, trade payables, and accrued expenses.

filing / Aug 13, 2026 / receipt

In January 2022, the Company entered into an 8-year office lease agreement for a 20,116 square feet facility in Brisbane, California (“Brisbane Lease”).

filing / Aug 13, 2026 / receipt

This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.

filing / Jul 17, 2026 / receipt

executives
Christopher M. Lindblom Vice President - receipt
Jeffrey E. Young Chief Financial Officer - receipt
Justin Trojanowski Vice President - receipt
Louis J. Arcudi III Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled webcast / ir
changes
2026-06-04 Vice President, appointed sec_8k
2022-09-23 Director, appointed sec_8k
2021-01-28 Chief Executive Officer, appointed sec_8k
2019-06-18 Chief Medical Officer, departed sec_8k
2014-09-18 Chief Financial Officer, appointed sec_8k
2013-06-13 Vice President, appointed sec_8k
mcp_package_hint
steadybase-$